Post job

Recipharm CEO and executives

Executive Summary. Based on our data team's research, Marc Funk is the Recipharm's CEO. Recipharm has 8,666 employees, of which 19 are in a leadership position.
Here are further demographic highlights of the leadership team:
  • The Recipharm executive team is 42% female and 58% male.
  • 75% of the management team is White.
  • 10% of Recipharm management is Hispanic or Latino.
  • 11% of the management team is Black or African American.
Work at Recipharm?
Share your experience

Rate Recipharm's leaders' effectiveness in guiding the company.

Zippia waving zebra
Name & TitleBio
Marc Funk

Chief Executive Officer

Lars Backsell

Founder

Thomas Eldered

Founder

Frank Ternes

Head of Business Unit Sterile Fill & Finish

Richard Ridinger

Chairman of The Board

Steven M. Klosk

Board Member

Daniela Sylvia Beate Roxin

Chief Financial Officer

Mark Burgess Keatley

Board Member

Christiane Hanke-Harloff

Board Member

Erika Karin Elisabeth Henriksson

Board Member

Do you work at Recipharm?

Does the leadership team provide a clear direction for Recipharm?

Recipharm jobs

Recipharm founders

Name & TitleBio
Lars Backsell

Founder

Thomas Eldered

Founder

Recipharm board members

Name & TitleBio
Richard Ridinger

Chairman of The Board

Steven M. Klosk

Board Member

Mark Burgess Keatley

Board Member

Christiane Hanke-Harloff

Board Member

Erika Karin Elisabeth Henriksson

Board Member

Henrik Giver

Board Member

Dr Eva Saers

Board Member

Helena Levander

Board Member

Marianne Alexandersson

Board Member

Recipharm executives FAQs

Zippia gives an in-depth look into the details of Recipharm, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Recipharm. The employee data is based on information from people who have self-reported their past or current employments at Recipharm. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Recipharm. The data presented on this page does not represent the view of Recipharm and its employees or that of Zippia.

Recipharm may also be known as or be related to Recip and Recipharm.